🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
Vessels that encapsulate tumor clusters (VETC) are a novel invasive metasta...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-01
Trial ID
NCT07077798
Treatments Being Tested
Vessels that encapsulate tumor clusters (VETC) is an invasive metastatic fa...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Start Date
2024-04-01
Trial ID
NCT06311929
Treatments Being Tested
This is a multicenter, open-label, phase Ib/II study on the efficacy and sa...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2022-05-23
Trial ID
NCT05740215
Treatments Being Tested
This phase II, multicenter, single-arm, open-label study evaluates first-li...
Status
Not Yet Recruiting
Location
West China Hospital, Chengdu, Sichuan 610000
Start Date
2026-08
Trial ID
NCT07715565
Treatments Being Tested
Purpose: This phase II clinical trial evaluates whether a combination of li...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07685535
Treatments Being Tested
This is a parallel assigned, open-label, perspective trial studying the saf...
Status
Unknown
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2022-05-20
Trial ID
NCT05339581
The vast majority of primary liver cancer (90%) is hepatocellular carcinoma...
Status
Unknown
Location
Tianjin Medical University Cancer Hospital
Start Date
2019-11-14
Trial ID
NCT04273100
Treatments Being Tested
In many cancers, early stage diagnosis and early treatment offers the best ...
Status
Withdrawn
Location
Melanoma Institute Australia
Start Date
2024-03
Trial ID
NCT05545969
Treatments Being Tested